Augmedix Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	133	242	58	117	-	-	-
Market Cap Growth	-	314.39%	-50.11%	-	-	-	-
Enterprise Value	112	221	54	91	-8	1	4
PE Ratio	-12.62	-12.62	-2.39	-6.70	-	-	-
PS Ratio	2.96	5.40	1.89	5.28	-	-	-
PB Ratio	5.69	10.38	39.83	4.86	-	-	-
P/FCF Ratio	-13.05	-13.05	-3.21	-6.10	-	-	-
P/OCF Ratio	-15.67	-15.67	-3.48	-6.30	-	-	-
EV/Sales Ratio	2.50	4.94	1.75	4.08	-0.50	0.06	0.33
EV/EBITDA Ratio	-15.14	-15.14	-2.55	-6.25	0.62	-0.06	-0.18
EV/EBIT Ratio	-13.20	-13.20	-2.38	-5.97	0.58	-0.05	-0.16
EV/FCF Ratio	-11.94	-11.94	-2.97	-4.71	0.54	-0.05	-0.18
Debt / Equity Ratio	1.11	1.11	11.58	0.62	4.79	-0.19	-0.29
Debt / EBITDA Ratio	-1.77	-1.77	-0.80	-1.03	-1.13	-0.86	-0.67
Debt / FCF Ratio	-1.39	-1.39	-0.93	-0.77	-0.99	-0.82	-0.67
Quick Ratio	2.33	2.33	1.44	3.47	1.57	1.09	1.34
Current Ratio	2.41	2.41	1.53	3.63	1.63	1.12	1.38
Asset Turnover	0.97	0.97	0.79	0.74	0.76	0.95	-
Interest Coverage	-7.44	-7.44	-13.53	-6.73	-9.74	-5.58	-10.60
Return on Equity (ROE)	-308.50%	-308.50%	-262.50%	-622.50%	50.30%	33.00%	-
Return on Assets (ROA)	-41.60%	-41.60%	-62.00%	-58.40%	-71.50%	-124.40%	-
Return on Capital (ROIC)	-38.19%	-38.19%	-121.32%	-45.11%	-75.76%	31.87%	68.62%
Earnings Yield	-14.45%	-7.92%	-41.87%	-14.92%	-	-	-
FCF Yield	-13.98%	-7.66%	-31.13%	-16.41%	-	-	-
Buyback Yield / Dilution	-17.45%	-17.45%	-29.41%	-311.09%	-745.81%	30.08%	-
Total Shareholder Return	-17.45%	-17.45%	-29.41%	-311.09%	-745.81%	30.08%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).